Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age

Lynch, 2009, Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention, Semin Respir Crit Care Med, 30, 189, 10.1055/s-0029-1202938 Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP), 1997, MMWR Recomm Rep, 46, 1 Jackson, 2013, Pneumococcal polysaccharide vaccines, 542 Centers for Disease Control Prevention (CDC); Advisory Committee on Immunization Practices, 2010, Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23), MMWR Morb Mortal Wkly Rep, 59, 102 Granoff, 1998, Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination, J Infect Dis, 178, 870, 10.1086/515346 World Medical Association (WMA). WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. <http://www.wma.net/en/30publications/10policies/b3/index.html> [accessed 2.08.13]. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Efficacy Guidelines. Good Clinical Practice E6. <http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html> [accessed 2.08.13]. Cooper, 2011, The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A, Vaccine, 29, 7207, 10.1016/j.vaccine.2011.06.056 de Roux, 2008, Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory, Clin Infect Dis, 46, 1015, 10.1086/529142 Chan, 1999, Test-based exact confidence intervals for the difference of two binomial proportions, Biometrics, 55, 1202, 10.1111/j.0006-341X.1999.01202.x Centers for Disease Control and Prevention (CDC), 2012, Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older, MMWR Morb Mortal Wkly Rep, 61, 394 Törling, 2003, Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia, Vaccine, 22, 96, 10.1016/S0264-410X(03)00521-8 Musher, 2010, Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults, J Infect Dis, 201, 516, 10.1086/649839 Jackson, 2013, Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older, Vaccine, 31, 3594, 10.1016/j.vaccine.2013.04.084 Richmond, 2000, Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine, J Infect Dis, 181, 761, 10.1086/315284 Borrow, 2001, Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children, J Infect Dis, 184, 377, 10.1086/322024 Brynjolfsson, 2012, Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells, J Infect Dis, 205, 422, 10.1093/infdis/jir750 Clutterbuck, 2012, Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells, J Infect Dis, 205, 1408, 10.1093/infdis/jis212 Goldblatt, 2002, Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults, J Infect Dis, 185, 397, 10.1086/338474 Leggat, 2013, The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells, J Infect Dis, 208, 101, 10.1093/infdis/jit139 Gruber, 2012, Development and clinical evaluation of Prevnar 13, a 13-valent pneumococcal CRM197 conjugate vaccine, Ann N Y Acad Sci, 1263, 15, 10.1111/j.1749-6632.2012.06673.x Centers for Disease Control and Prevention (CDC), 2012, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Mrb Mortal Wkly Rep, 61, 816 Jackson, 2013, Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults, Vaccine, 31, 3577, 10.1016/j.vaccine.2013.04.085 Jackson, 2013, Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine, Vaccine, 31, 3585, 10.1016/j.vaccine.2013.05.010 O’Brien, 2007, Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?, Lancet Infect Dis, 7, 597, 10.1016/S1473-3099(07)70210-4 De Roux, 2008, Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory, Clin Infect Dis, 46, 1015, 10.1086/529142 Goldblatt, 2009, The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years, Clin Infect Dis, 49, 1318, 10.1086/606046 Shelly, 1997, Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults, Infect Immun, 65, 242, 10.1128/IAI.65.1.242-247.1997 Miernyk, 2009, Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in Alaska native adults 55-70 years of age, Clin Infect Dis, 49, 241, 10.1086/599824